ARCHIVES

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

This article is from The Cancer Letter archive.

Vol. 30 No. 26 | June 25, 2004

Download PDF Visit The Full Archive

Related Articles

New Mexico Program Covers Entire State

January 21, 1977

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

HHS Orders Gallo Forum Canceled; Meeting May Be Held After OSI report final – Calabresi

July 3, 1992

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013

Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting.

December 7, 2007

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976